| 臺大學術典藏 |
2022-08-12T02:50:36Z |
A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapy
|
Chou Y.-J.; Kober K.M.; KUN-HUEI YEH; Cooper B.A.; Kuo C.-H.; Lin B.-R.; Kuo T.-C.; Tseng Y.J.; Miaskowski C.; Shun S.-C. |
| 臺大學術典藏 |
2022-08-12T02:50:36Z |
Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancer
|
Liang Y.-H.; Liang J.-T.; Lin B.-R.; Huang J.; Hung J.-S.; Lai S.-L.; Chen T.-C.; Tsai J.-H.; Cheng Y.-M.; Tsao T.-H.; Hsu W.-L.; Chen K.-H.; KUN-HUEI YEH |
| 臺大學術典藏 |
2022-08-12T02:50:35Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
Kuo S.-H.; KUN-HUEI YEH; Lin C.-W.; Liou J.-M.; Wu M.-S.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-04-14T23:27:36Z |
Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancer
|
YI-HSIN LIANG; JIN-TUNG LIANG; Lin, Ben Ren; TAI-CHUNG HUANG; JI-SHIANG HUNG; Lai, Shuo Lun; Chen, Tzu Chun; JIA-HUEI TSAI; Cheng, Yung Ming; Tsao, Ting Han; Hsu, Wen Ling; Chen, Kuo Hsing; KUN-HUEI YEH |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; KUN-HUEI YEH; CHUNG-WU LIN; JYH-MING LIOU; MING-SHIANG WU; Chen, Li Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-14T23:55:41Z |
A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapy
|
Chou, Yun Jen; Kober, Kord M.; KUN-HUEI YEH; Cooper, Bruce A.; CHING-HUA KUO; BEEN-REN LIN; Kuo, Tien Chueh; Tseng, Yufeng J.; Miaskowski, Christine; SHIOW-CHING SHUN |
| 臺大學術典藏 |
2022-01-05T03:36:40Z |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
|
Kang Y.-K.; Morita S.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Chen L.-T.; Boku N. |
| 臺大學術典藏 |
2022-01-05T03:36:40Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2022-01-05T03:36:39Z |
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
|
Boku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Nishiyama T.; Chen L.-T.; Kang Y.-K. |
| 臺大學術典藏 |
2022-01-05T03:36:39Z |
Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing
|
Liang Y.-H.; Tsai J.-H.; Cheng Y.-M.; Chan K.-Y.; Hsu W.-L.; Lee C.-C.; Chen K.-H.; KUN-HUEI YEH |
